P&G Beauty Growth Abroad Offsets Challenges In U.S. In Q4
This article was originally published in The Rose Sheet
Executive Summary
Growth of Procter & Gamble's beauty business in developing markets kept the unit afloat in the fourth quarter and fiscal year 2011, despite challenges in the U.S. including the recall of Olay UV products and a continuing rebuild of Pantene equity.
You may also be interested in...
In Brief
In a letter to FDA, Johnson & Johnson and Energizer propose a study exploring questions FDA has raised about previous studies on sun-protection products with SPF values greater than 50. Separately, Reckitt Benckiser divests Indian personal-care brands and Revlon and Givaudan report sales and earnings for fiscal 2011. More news in brief.
P&G To Hike Prices At Least 3%, Expects Others To Follow
Procter & Gamble expects that an across-the-board price increase of at least 3% – spurred by higher commodity costs – will prompt its competitors to raise product prices as well.
P&G To Hike Prices At Least 3%, Expects Others To Follow
Procter & Gamble expects that an across-the-board price increase of at least 3% – spurred by higher commodity costs – will prompt its competitors to raise product prices as well.